• Emerging immunotherapies for rheumatoid arthritis
  • Risk of cervical HPV infection and prevalence of vaccine-type and other high-risk HPV types among sexually active teens and young women (13–26 years) enrolled in the VALHIDATE study
  • Postoperative dendritic cell vaccine plus activated T-cell transfer improves the survival of patients with invasive hepatocellular carcinoma
  • Review of meningococcal vaccines with updates on immunization in adults
  • Characterization of the biological anti-staphylococcal functionality of hUK-66 IgG1, a humanized monoclonal antibody as substantial component for an immunotherapeutic approach
  • Effectiveness of 10-year vaccination (2001–2010) on Hepatitis A in Tianjin, China

Emerging immunotherapies for rheumatoid arthritis

Gary Reynolds, Faye AH Cooles, John D Isaacs and Catharien MU Hilkens

Risk of cervical HPV infection and prevalence of vaccine-type and other high-risk HPV types among sexually active teens and young women (13–26 years) enrolled in the VALHIDATE study

Giovanna Orlando, Michela Fasolo, Francesca Mazza, Elena Ricci, Susanna Esposito, Elena Frati, Gian Vincenzo Zuccotti, Irene Cetin, Maria Gramegna, Giuliano Rizzardini, Elisabetta Tanzi and VALHIDATE study group

Postoperative dendritic cell vaccine plus activated T-cell transfer improves the survival of patients with invasive hepatocellular carcinoma

Koichi Shimizu, Yoshihito Kotera, Atsushi Aruga, Nobuhiro Takeshita, Satoshi Katagiri, Shun-ichi Ariizumi, Yutaka Takahashi, Kenji Yoshitoshi, Ken Takasaki and Masakazu Yamamoto

Review of meningococcal vaccines with updates on immunization in adults

Yorgo C Zahlanie, Moza M Hammadi, Soha T Ghanem and Ghassan S Dbaibo

Characterization of the biological anti-staphylococcal functionality of hUK-66 IgG1, a humanized monoclonal antibody as substantial component for an immunotherapeutic approach

Babett Oesterreich, Birgit Lorenz, Tim Schmitter, Roland Kontermann, Michael Zenn, Bastian Zimmermann, Markus Haake, Udo Lorenz and Knut Ohlsen

Effectiveness of 10-year vaccination (2001–2010) on Hepatitis A in Tianjin, China

Zhi-lun Zhang, Xiang-jun Zhu, Ai-lan Shan, Zhi-gang Gao, Ying Zhang, Ya-xing Ding, Hui Liu, Wei-shen Wu, Yong Liu, Hai-yan He, Xiao-hua Xie, Wei-dong Xia, Chao Li, Wen-ti Xu, Zhi-yuan Li, Hua-Liang Lin and Wei-ming Fu

Current Issue

Human Vaccines & Immunotherapeutics

April 2014

Volume 10, Issue 4

View current issue

About the cover image
Three-dimensional reconstructions of HPV11 decorated with antibody fragment H11.B2 B2. For more information see Zhao et al.  

Open Access

Human Vaccines & Immunotherapeutics offers a highly competitive open access fee for authors who wish for free access to and distribution of published articles. Authors retain copyright of their work by utilizing a Creative Commons attribution license. Open Access papers will be submitted to PubMed Central immediately upon final publication of each issue.

Open Access Fees

Research Papers and Reports, OA fee is $750.00 USD

Reviews, Brief Reports and Short Communications, OA fee is $500.00 USD

All other types of papers, OA fee is $250.00

Journal Description

Human Vaccines & Immunotherapeutics is a unique peer-reviewed journal, focused exclusively on vaccines and immunotherapeutics for humans.

Vaccine research and development is extending its reach beyond the prevention of bacterial or viral diseases. There are experimental vaccines for immunotherapeutic purposes and for applications outside of infectious diseases, in diverse fields such as cancer, autoimmunity, allergy, Alzheimer’s and addiction. Many of these vaccines and immunotherapeutics should become available in the next two decades, with consequent benefit for human health. Continued advancement in this field will benefit from a forum that can help to promote interest by keeping investigators updated as well as to enable an exchange of ideas regarding the latest progress in the many topics pertaining to vaccines and immunotherapeutics.

Human Vaccines & Immunotherapeutics provides such a forum. It is published monthly in a format that is accessible to a wide international audience in the academic, industrial and public sectors. Articles cover topics including but not limited to research, development, clinical, regulatory, production, epidemiology, effectiveness, health economics, use in the field, perceptions, acceptance, and safety.

Recent Articles

Most Popular Downloads